Iron Oxide Nanoparticle-Based MRI Contrast Agents: Characterization and In Vivo Use

A simple and efficient method to synthesize highly water-dispersible calcium lignosulfonate-coated manganese oxide nanoparticles as a potential candidate for the current magnetic resonance imaging (MRI) T 1 contrast agents was reported. Hydrophobic MnO nanoparticles with dimensions of about 10 nm were prepared by thermal decomposition of manganese(II)acetylacetonate in the presence of oleic acid as a surfactant. The characteristics of the synthesized nanoparticles, cytotoxicity assay and in vitro MRI properties were investigated in detail. Results showed that calcium lignosulfonate has a great influence on the colloidal stability and biocompatibility of MnO nanoparticles in water. Furthermore, this coating agent ensures abundant exposure of external Mn ion with protons of water, which endows the nanoparticles with a longitudinal molar relaxivity (r 1 ) of 4.62 mM À1 s À1 . An efficient contrast enhancement effect was observed in the study of MRI investigations. † Electronic supplementary information (ESI) available: Zeta potential of MnO-CaLs NPs; solid-state UV absorption spectra of MnO-OA NPs, CaLs and MnO-CaLs NPs; signal intensity against TR in T 1 -weighted MRI images and signal intensity against TE in T 2 -weighted MRI images. See Fig. 7 The viability of human fibroblast cells HFFF2 treated with different concentration of CaLs and MnO-CaLs NPs for 24 h measured by MTT assay.40504 | RSC Adv., 2019,9,[40498][40499][40500][40501][40502][40503][40504][40505][40506] This journal is

show abstract

Iron Oxide Nanoparticle-Based MRI Contrast Agents: Characterization and In Vivo Use

Cited by 2 publications

References 144 publications

Nanomaterials for Medical Imaging and In Vivo Sensing

Nanomaterials for Medical Imaging and In Vivo Sensing

Highly water-dispersible calcium lignosulfonate-capped MnO nanoparticles as a T₁ MRI contrast agent with exceptional colloidal stability, low toxicity and remarkable relaxivity

Contact Info

Product

Resources

About

Iron Oxide Nanoparticle-Based MRI Contrast Agents: Characterization and In Vivo Use

Cited by 2 publications

References 144 publications

Nanomaterials for Medical Imaging and In Vivo Sensing

Nanomaterials for Medical Imaging and In Vivo Sensing

Highly water-dispersible calcium lignosulfonate-capped MnO nanoparticles as a T1 MRI contrast agent with exceptional colloidal stability, low toxicity and remarkable relaxivity

Contact Info

Product

Resources

About

Highly water-dispersible calcium lignosulfonate-capped MnO nanoparticles as a T₁ MRI contrast agent with exceptional colloidal stability, low toxicity and remarkable relaxivity